News | November 29, 2025
Mangalam Drugs receives Rs. 15 crore repeat export order
The receipt of this order further strengthens the company's position in the global pharmaceutical market
The receipt of this order further strengthens the company's position in the global pharmaceutical market
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent
Subscribe To Our Newsletter & Stay Updated
